7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
      
    		                
      cash flows from operating activities:
    		                
      net income
    		-1,166,000,000 -1,115,000,000 -541,000,000 -743,000,000 -1,100,000,000 -1,457,000,000 -1,446,000,000 -1,521,000,000 -1,367,000,000 -1,195,000,000 -1,349,000,000 -1,723,000,000 -1,724,000,000 -1,712,000,000 -1,593,000,000 -2,461,000,000 
      depreciation and amortization
    		187,000,000 196,000,000 200,000,000 218,000,000 259,000,000 274,000,000 280,000,000 270,000,000 256,000,000 223,000,000 188,000,000 199,000,000 174,000,000 161,000,000 118,000,000 113,000,000 
      stock-based compensation expense
    		174,000,000 189,000,000 188,000,000 154,000,000 111,000,000 194,000,000 233,000,000 215,000,000 242,000,000 181,000,000 183,000,000  293,000,000 242,000,000 317,000,000  
      gain on equity method investment
    		0 0 -101,000,000              
      loss on convertible notes
    		               -17,000,000 
      other non-cash activities
    		-46,000,000 20,000,000 20,000,000 -57,000,000 30,000,000 2,000,000 53,000,000 69,000,000 39,000,000 5,000,000 2,000,000 -5,000,000 24,000,000 16,000,000 47,000,000 12,000,000 
      changes in operating assets and liabilities:
    		                
      accounts receivable
    		78,000,000 158,000,000 31,000,000 -225,000,000 31,000,000 140,000,000 -228,000,000 76,000,000 104,000,000 -184,000,000 -55,000,000 6,000,000 -45,000,000 -41,000,000 4,000,000  
      inventory
    		403,000,000 472,000,000 -364,000,000 515,000,000 -83,000,000 310,000,000 -435,000,000 -133,000,000 -281,000,000 -409,000,000 -781,000,000 -454,000,000 -583,000,000 -253,000,000 -367,000,000 -212,000,000 
      other assets
    		-64,000,000 24,000,000 14,000,000 -180,000,000 22,000,000 18,000,000 -81,000,000          
      accounts payable and accrued liabilities
    		368,000,000 -214,000,000 334,000,000 -233,000,000 -82,000,000 -370,000,000 113,000,000 -115,000,000 204,000,000 -6,000,000 22,000,000 144,000,000 58,000,000 220,000,000 201,000,000  
      deferred revenues
    		92,000,000                
      other liabilities
    		0 -10,000,000 -28,000,000 47,000,000 35,000,000 142,000,000 92,000,000          
      net cash from operating activities
    		26,000,000 64,000,000 -188,000,000 1,183,000,000 -876,000,000 -754,000,000 -1,269,000,000 -1,107,000,000 -877,000,000 -1,361,000,000 -1,521,000,000 -1,446,000,000 -1,368,000,000 -1,204,000,000 -1,034,000,000 -1,086,000,000 
      cash flows from investing activities:
    		                
      purchases of equity securities and short-term investments
    		-629,000,000                
      sales of equity securities and short-term investments
    		                
      maturities of short-term investments
    		677,000,000 810,000,000 717,000,000 857,000,000 1,025,000,000 1,121,000,000 550,000,000 700,000,000         
      capital expenditures
    		-447,000,000 -462,000,000 -338,000,000 -327,000,000 -277,000,000 -283,000,000 -254,000,000 -298,000,000 -190,000,000 -255,000,000 -283,000,000 -294,000,000 -298,000,000 -359,000,000 -418,000,000  
      free cash flows
    		-421,000,000 -398,000,000 -526,000,000 856,000,000 -1,153,000,000 -1,037,000,000 -1,523,000,000 -1,405,000,000 -1,067,000,000 -1,616,000,000 -1,804,000,000 -1,740,000,000 -1,666,000,000 -1,563,000,000 -1,452,000,000  
      net cash from investing activities
    		-393,000,000 -706,000,000 -408,000,000 -1,386,000,000 501,000,000 -489,000,000 -606,000,000 -603,000,000 -432,000,000 -1,193,000,000 -283,000,000 -294,000,000 -298,000,000 -359,000,000 -418,000,000 -456,000,000 
      cash flows from financing activities:
    		                
      proceeds from stock-based compensation programs
    		-2,000,000                
      proceeds from issuance of capital stock
    		0      2,000,000    3,000,000    1,000,000 4,000,000 
      proceeds from issuance of long-term debt
    		0                
      repayments of long-term debt
    		0                
      proceeds from issuance of convertible notes
    		   0 0   1,710,000,000 0 0 1,485,000,000     0 
      other financing activities
    		-1,000,000 -27,000,000 -9,000,000 -2,000,000 0 -1,000,000 -4,000,000 -3,000,000 -10,000,000 -2,000,000 -3,000,000      
      net cash from financing activities
    		-3,000,000 756,000,000 -6,000,000 104,000,000 4,000,000 1,030,000,000 -2,000,000 1,621,000,000 -8,000,000 32,000,000 1,485,000,000 37,000,000 6,000,000   14,760,000,000 
      effect of exchange rate changes on cash and cash equivalents
    		-1,000,000 5,000,000 1,000,000   -3,000,000 -1,000,000     2,000,000 -3,000,000    
      net change in cash
    		-371,000,000 119,000,000 -601,000,000 -102,000,000 -367,000,000 -216,000,000 -1,878,000,000 -84,000,000 -1,319,000,000 -2,520,000,000 -319,000,000 -1,701,000,000 -1,663,000,000 -1,508,000,000 -1,452,000,000 13,218,000,000 
      cash, cash equivalents, and restricted cash—beginning of period
    		0 0 5,294,000,000 0 0 0 7,857,000,000 0 0 0 12,099,000,000 0 0 0 18,423,000,000 0 
      cash, cash equivalents, and restricted cash—end of period
    		-371,000,000 119,000,000 4,693,000,000 -102,000,000 -367,000,000 -216,000,000 5,979,000,000 -84,000,000 -1,319,000,000 -2,520,000,000 11,780,000,000 -1,701,000,000 -1,663,000,000 -1,508,000,000 16,971,000,000 13,218,000,000 
      supplemental disclosure of non-cash investing and financing activities:
    		                
      capital expenditures included in liabilities
    		47,000,000 29,000,000 423,000,000 54,000,000 4,000,000 -18,000,000 383,000,000 -16,000,000 52,000,000 5,000,000 333,000,000 -10,000,000 16,000,000 -48,000,000 406,000,000 -14,000,000 
      capital stock issued to settle bonuses
    		0 0 47,000,000 0 0 0 179,000,000 0 0 0 137,000,000      
      right-of-use assets obtained in exchange for operating lease liabilities
    		90,000,000 61,000,000 73,000,000  35,000,000 35,000,000 52,000,000  39,000,000 16,000,000 11,000,000  20,000,000 30,000,000 54,000,000  
      *the prior period has been recast to conform to current period presentation.
    		                
      sales of short-term investments
    		 53,000,000 48,000,000              
      deferred revenue
    		  59,000,000              
      purchases of short-term investments
    		  -835,000,000 -1,916,000,000 -247,000,000 -1,327,000,000 -902,000,000          
      proceeds from issuance of capital stock including employee stock purchase plan
    		  3,000,000 27,000,000 4,000,000   22,000,000 2,000,000   37,000,000 7,000,000    
      inventory lcnrv write-downs and losses on firm purchase commitments
    		    -39,000,000 -97,000,000 150,000,000          
      proceeds from funding of 50% interest in rivian and vw group technology, llc
    		                
      purchase of capped call options
    		                
      supplemental disclosure of cash flow information:
    		                
      cash paid for interest
    		               1,000,000 
      conversion of convertible notes
    		                
      *the prior periods have been recast to conform to current period presentation.
    		                
      fair value loss on convertible note
    		    -60,000,000            
      other incomes
    		                
      other current assets
    		       0 -18,000,000 -33,000,000 -11,000,000 -15,000,000 -17,000,000 7,000,000 11,000,000  
      other non-current assets
    		       -17,000,000 -29,000,000 -20,000,000 -18,000,000 -8,000,000 5,000,000 -13,000,000 -6,000,000 -2,000,000 
      other current liabilities
    		       -21,000,000 41,000,000 38,000,000 15,000,000 7,000,000 45,000,000 19,000,000 33,000,000 38,000,000 
      other non-current liabilities
    		       77,000,000 38,000,000 48,000,000 54,000,000 44,000,000 25,000,000 26,000,000 6,000,000  
      proceeds from share issuance upon initial public offering, net of underwriting discounts and commissions and offering costs
    		                
      conversion of convertible preferred stock
    		                
      inventory lcnrv charge and losses on firm purchase commitments
    		                
      purchase of short-term investments
    		        -467,000,000        
      inventory write-downs and losses on firm purchase commitments
    		         -9,000,000 229,000,000 224,000,000 395,000,000 113,000,000 188,000,000  
      stock-based compensation
    		                
      proceeds from issuance of long-term debt, net of discount and debt issuance costs
    		                
      principal payments and other financing activities
    		           0 -1,000,000 -1,000,000 -1,000,000  
      warrants issuance
    		                
      customer deposits
    		             11,000,000 7,000,000 26,000,000 
      write-down of inventory
    		               64,000,000 
      amortization of debt discounts and issuance costs
    		                
      current assets
    		                
      payables and accrued liabilities
    		                
      non-current liabilities
    		                
      decrease in note receivable due from affiliate
    		                
      capital expenditures—property, plant, and equipment
    		                
      capital expenditures—intangible assets
    		                
      proceeds from sale of fixed assets
    		                
      debt issuance costs
    		                
      principal payments on long-term debt
    		                
      principal payments under finance lease obligations
    		                
      supplemental disclosures of cash flow information:
    		                
      supplemental disclosure of non-cash investing activities:
    		                
      issuance of warrants
    		                
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.